Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...
Opinion
11hOpinion
Counting Our Days in 2026: Why a Veteran Dean Says Leaders Are Facing a Purpose Crisis
KNOXVILLE, TN, UNITED STATES, January 5, 2026 /EINPresswire.com/ — As the nation enters a new year marked by artificial intelligence disruption, executive burnout, delayed retirements, and declining ...
Jan. 5 (1:24 p.m.): Gavin Jenkins, a rising redshirt freshman, has signed with Auburn, a source confirmed to the Montgomery ...
Arizona’s 90 lawmakers will return to the state Capitol in less than a week to kick off the next legislative session, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback